Vendor, Newark, CA, part of Dna Twopointo Inc.
Dna Twopointo Inc.
UEI G9S3SC8T5DM1, CAGE 3ENW7
1 award and $225,000 obligated between May 6, 2024 and July 20, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $225,000 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Hear when Dna Twopointo Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Dna Twopointo Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $225,000
- Soonest
- May 13, 2028
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling biological product (except diagnostic) manufacturing to National Institutes of Health, by dollars.
| Miltenyi Biotec, Inc.Auburn, CA | $9,230,186 |
| Somalogic Operating Co., Inc.Boulder, CO | $5,105,945 |
| Vector Biomed Inc.Gaithersburg, MD | $2,068,000 |
| Loyola University of ChicagoMaywood, IL | $1,083,035 |
| Speed Biosystems, LLCPotomac, MD | $1,037,625 |
| Bioivt, LLCWoodbury, NY | $768,107 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023P00594Purchase Order, May 6, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Yearly License (Maintenance Fee and Ind Filing Fee) to Use a Monoclonal Antibody Produced Via Atum Proprietary Cell Line TechnologyNAICS 325414, PSC 6505 | $225,000 |
- Places of performance
- California
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 3 across 1 awards